Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma
Clinical trial NCT02238873 · UNKNOWN
Trial details
- NCT number
- NCT02238873
- Sponsor
- Rabin Medical Center
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2018-01-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.